Vulvovaginal Atrophy: Clinical Trials

2 trials for Vulvovaginal Atrophy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1

Follow Vulvovaginal Atrophy: new trials by email Literature Review of Vulvovaginal Atrophy trials Research Report on Vulvovaginal Atrophy

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women
IVR Dose 1, IVR Dose 2 - Vulvovaginal Atrophy, Vasomotor Symptoms
Phase 1 / Phase 2CompletedDaré Bioscience, Inc.212022-04-112024-10-31
A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women
IVR Dose 1, IVR Dose 2, Oral Reference - Vulvovaginal Atrophy, Vasomotor Symptoms
Phase 1CompletedDaré Bioscience, Inc.342020-08-182024-10-15

Sponsors

Daré Bioscience, Inc. (2)

Countries

Australia (2)

Top investigators

David Friend, PhD (1)

Results publications

PMID 37339390, PMID 37625088